We exhibited for the first time at CPHI WW 2022 in Frankfurt.

For yet another year, hosting +2,000 exhibitors and +45,000 visitors from +150 countries, CPHI WW consolidates its position as the most influential pharmaceutical exhibition on a global scale.

We are pleased to have been present among the most prestigious international companies in major markets, collaborating with our parent company Otsuka Chemical Co, Ltd.

At Hebron, being experts in synthesizing organic chemistry through the Cyanation reaction, we presented our fully integrated and adaptable CDMO capabilities specialized in the production of amides, nitriles, and amino acid precursors.

Otsuka Chemical Co., Ltd, presented their CDMO capabilities to manufacture unusual amino acids and specific building blocks for custom peptides and DNA/RNA. They also synthesize amidites, nucleotides, nucleosides, and custom oligonucleotides.

We would like to thank our business partners and visitors for the interest shown in the services and products we offer.

We look forward to seeing you again at the next edition, in Barcelona!